MILLER MICHAEL PATRICK
SEC CIK 1236514 · EDGAR
BoughtSold
Most active insiders at PBYI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | AUERBACH ALAN H | Pres, CEO, Dir, 10% | — | $568.9K |
| 2 | Cesano Alessandra | Dir | — | $567.0K |
| 3 | Senderowicz Adrian | Dir | — | $194.3K |
| 4 | MOYES JAY M | Dir | — | $158.8K |
| 5 | NOUGUES MAXIMO F | CFO | — | $141.7K |
| 6 | WILSON TROY EDWARD | Dir | — | $123.2K |
| 7 | HUNT DOUGLAS M | See Remarks | — | $122.6K |
| 8 | MILLER MICHAEL PATRICK | Dir | — | $97.2K |
| 9 | Dorval Allison | Dir | — | $83.6K |
| 10 | Stuglik Brian M | Dir | — | $58.3K |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-15 20:12 | 2026-06-11 | PBYI | PUMA BIOTECHNOLOGY, INC. | MILLER MICHAEL PATRICK | Dir | A - Grant | $0.00 | +27.0K | 81.0K | +50% | $0 | |
| 2026-05-19 20:49 | 2026-05-15 | RIGL | RIGEL PHARMACEUTICALS INC | MILLER MICHAEL PATRICK | Dir | A - Grant | $0.00 | +5,750 | 5,937 | +3,075% | $0 | |
| 2025-11-13 | 2025-11-11 | PBYI | PUMA BIOTECHNOLOGY, INC. | MILLER MICHAEL PATRICK | Dir | S - Sale | $4.86 | -20.0K | 54.0K | -27% | -$97.2K | |
| 2025-06-13 | 2025-06-11 | PBYI | PUMA BIOTECHNOLOGY, INC. | MILLER MICHAEL PATRICK | Dir | A - Grant | $0.00 | +27.0K | 74.0K | +57% | $0 | |
| 2024-08-13 | 2024-08-12 | PBYI | PUMA BIOTECHNOLOGY, INC. | MILLER MICHAEL PATRICK | Dir | S - Sale | $3.49 | -23.4K | 47.0K | -33% | -$81.5K | |
| 2024-06-21 | 2024-06-18 | PBYI | PUMA BIOTECHNOLOGY, INC. | MILLER MICHAEL PATRICK | Dir | A - Grant | $0.00 | +27.0K | 95.4K | +39% | $0 | |
| 2023-11-09 | 2023-11-07 | PBYI | PUMA BIOTECHNOLOGY, INC. | MILLER MICHAEL PATRICK | Dir | S - Sale | $2.83 | -25.0K | 43.4K | -37% | -$70.8K | |
| 2023-06-15 | 2023-06-13 | PBYI | PUMA BIOTECHNOLOGY, INC. | MILLER MICHAEL PATRICK | Dir | S - Sale | $3.45 | -13.5K | 41.4K | -25% | -$46.6K | |
| 2023-06-15 | 2023-06-13 | PBYI | PUMA BIOTECHNOLOGY, INC. | MILLER MICHAEL PATRICK | Dir | A - Grant | $0.00 | +27.0K | 68.4K | +65% | $0 | |
| 2022-08-10 | 2022-08-09 | PBYI | PUMA BIOTECHNOLOGY, INC. | MILLER MICHAEL PATRICK | Dir | S - Sale | $3.55 | -25.0K | 54.9K | -31% | -$88.8K | |
| 2022-06-16 | 2022-06-14 | PBYI | PUMA BIOTECHNOLOGY, INC. | MILLER MICHAEL PATRICK | Dir | A - Grant | $0.00 | +27.0K | 79.9K | +51% | $0 | |
| 2022-03-17 | 2022-03-16 | PBYI | PUMA BIOTECHNOLOGY, INC. | MILLER MICHAEL PATRICK | Dir | S - Sale | $2.80 | -25.7K | 52.9K | -33% | -$71.8K |
Purchase Sale Sale after option exercise All abbreviations